Filing Details
- Accession Number:
- 0001209191-21-009720
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-02-11 16:39:52
- Reporting Period:
- 2021-02-09
- Accepted Time:
- 2021-02-11 16:39:52
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1641281 | Bolt Biotherapeutics Inc. | BOLT | () | G7 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1388325 | A/S Holdings Novo | Tuborg Havnevej 19 Hellerup G7 2900 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-02-09 | 4,027,088 | $0.00 | 4,103,991 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2021-02-09 | 400,000 | $20.00 | 4,503,991 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Direct | |
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | SERIES A-1 PREFERRED STOCK | Disposition | 2021-02-09 | 1,096,323 | $0.00 | 1,096,323 | $0.00 |
| Common Stock | SERIES B PREFERRED STOCK | Disposition | 2021-02-09 | 2,050,758 | $0.00 | 2,050,758 | $0.00 |
| Common Stock | SERIES C-1 PREFERRED STOCK | Disposition | 2021-02-09 | 421,670 | $0.00 | 421,670 | $0.00 |
| Common Stock | SERIES C-2 PREFERRED STOCK | Disposition | 2021-02-09 | 458,337 | $0.00 | 458,337 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct |
Footnotes
- Each share of Series A-1 Preferred Stock, Series B Preferred Stock, Series C-1 Preferred Stock and Series C-2 Preferred Stock (collectively, the "Preferred Stock") converted automatically into one share of Common Stock upon the closing of the Issuer's initial public offering. These shares have no expiration date.
- Represents a purchase from the underwriters in the Issuer's initial public offering.
Billionaire Hedge Funds
